| 3D | Tridimensional |
| ADRC | Adult-derived regenerative cells |
| BAM | Bladder acellular matrix |
| bFGF | Basic fibroblast growth factor |
| BM-MSC | Bone marrow mesenchymal stem cells |
| BMP4 | Bone phosphogenic protein 4 |
| BSM | Bladder submucosa |
| ECM | Extracellular matrix |
| EDTA | Ethylenediamine tetra-acetic acid |
| EGF | Epithermal growth factor |
| FDA | Food and Drug Administration |
| GATA4 | GATA4 binding protein |
| HA | Hyaluronic acid |
| HBSMCs | Human bladder smooth muscle cells |
| HGF | Hepatic growth factor |
| IFR1 | Interferon regulatory factor 1 |
| IGF-1 | Insulin growth factor 1 |
| iPSCs | Induced pluripotent stem cells |
| KGF | Keratin growth factor |
| M | Million |
| MSC | Mesenchymal stem cells |
| PCL | Poly(ε-caprolactone) |
| PDGF | Platelet derived growth factor |
| PGA | Polyglicolic acid |
| PLA | Polylactic acid |
| PLAC | Collagen-Poly(lactic acid-co-ε-caprolactone) |
| PLGA | Co-poly(lactic/glycolic) acid |
| PLLA | Poly-l-Lactic |
| PS | Performance status |
| Q1 | First quartile |
| SEM | Scanning electron microscopy |
| SIS | Small intestine submucosa |
| SMCs | Smooth muscle cells |
| TEP | Tissue-engineered pericardium |
| TGF | Transforming growth factor alpha |
| UBM | Urinary bladder membrane |
| UCs | Urothelial cells |
| VE | Vesical equivalent |
| VEGF | Vascular endothelial growth factor |